Immatics N.V. Files 2024 Annual Report
Ticker: IMTX · Form: 20-F · Filed: Mar 27, 2025 · CIK: 1809196
Sentiment: neutral
Topics: annual-report, biotechnology, collaboration
Related Tickers: IMTX
TL;DR
Immatics filed its 2024 20-F, showing collaborations with Genmab & BMS, and financial data as of Dec 31, 2024.
AI Summary
Immatics N.V. filed its 20-F annual report for the fiscal year ending December 31, 2024. The company, based in Tübingen, Germany, is involved in biological products. Key collaborations mentioned include agreements with Genmab and BMS, with specific dates for these agreements noted as starting in 2022 and 2023 respectively. The filing also references financial details such as accumulated depreciation and amortization as of December 31, 2024.
Why It Matters
This filing provides investors with a comprehensive overview of Immatics N.V.'s financial performance, business operations, and strategic partnerships for the past fiscal year.
Risk Assessment
Risk Level: medium — As a biotechnology company, Immatics is subject to inherent risks related to drug development, regulatory approvals, and market competition.
Key Numbers
- 2024-12-31 — Fiscal Year End (The period covered by the annual report.)
- 2025-03-27 — Filing Date (The date the 20-F was submitted to the SEC.)
Key Players & Entities
- Immatics N.V. (company) — Filer of the 20-F report
- Genmab (company) — Collaborator mentioned in the filing
- BMS (company) — Collaborator mentioned in the filing
- 2024-12-31 (date) — Fiscal year end date for the report
- 2025-03-27 (date) — Filing date of the 20-F report
FAQ
What is the primary business of Immatics N.V. as indicated in the filing?
Immatics N.V. is involved in the business of Biological Products (No Diagnostic Substances), as per the Standard Industrial Classification code [2836].
When did the collaboration agreement with Genmab begin?
The Genmab Collaboration Agreement is noted with a period of 2022-01-01 to 2022-12-31.
What is the company's fiscal year end date?
The fiscal year end date for Immatics N.V. is December 31 (1231).
What is the SEC file number for Immatics N.V.'s 20-F filing?
The SEC file number is 001-39363.
What is the business address of Immatics N.V.?
The business address is Paul Ehrlich-Strasse 15, Tübingen, 72076, Germany.
Filing Details
This Form 20-F (Form 20-F) was filed with the SEC on March 27, 2025 regarding Immatics N.V. (IMTX).